Evidence map›Paper›PMID 34839650›Full record

ArticleJournal of public health research2021

Asbestos and cancer in Latin America and the Caribbean: we may have won some battles, but definitely not the war.

Abraham Hernández-Blanquisett, Angelina Álvarez-Londoño, Maria Cristina Martinez-Avila, Sofía Covo-Camacho, Valeria Quintero-Carreño

Open access · goldAbstract read
In one paragraph

Article in Journal of public health research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. A comprehensive multidisciplinary approach for identifying asbestos exposure among underground workers.Revista brasileira de medicina do trabalho : publicacao oficial da Associacao Nacional de Medicina do Trabalho-ANAMT
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Abraham Hernández-BlanquisettInstituto de Cáncer, Centro Hospitalario Serena del Mar, Cartagena. abrahan.hernandez@chsm.com.
Angelina Álvarez-LondoñoInstituto de Cáncer, Centro Hospitalario Serena del Mar, Cartagena. angelina.alvarez@chsm.com.
Maria Cristina Martinez-AvilaInstituto de Cáncer, Centro Hospitalario Serena del Mar, Cartagena. maria.martinez@chsm.com.
Sofía Covo-CamachoInstituto de Cáncer, Centro Hospitalario Serena del Mar, Cartagena. sofia.covo@chsm.com.
Valeria Quintero-CarreñoInstituto de Cáncer, Centro Hospitalario Serena del Mar, Cartagena. valeria.quintero@chsm.com.
Hospital la Serena · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Only six countries have banned the industrial use of asbestos in Latin America and the Caribbean. In fact, the industrial use of asbestos appears to be growing in this region. Asbestos is one of the most dangerous natural substances in the world, it is contained in several types of rocks (such as serpentinites, mafic and ultramafic rocks) but fibers can be released to the atmosphere both by natural and antropogenic sources. Six countries have banned the industrial use of asbestos in this region, we expected that laws established before 2007 would be less adherent to the 2007 WHO/ILO recommendations. In contrast, the Chilean law of 2001 is one of those that most adheres to international recommendations along with the Colombian law of 2021. Which means that the newest laws are not necessarily the strongest. This article aims to draw a regional overview of the laws against asbestos production in Latin America and the Caribbean, highlighting the strengths and weaknesses of each national policy. We recommend that countries that have already banned asbestos consider updating and strengthening their existing laws and develop clinical guidelines for the management, monitoring, and rehabilitation of asbestos-related diseases. The challenge of asbestos goes far beyond a prohibition law.

Identifiers

PMID34839650
PMCPMC8958443
OpenAlexW3215930631

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.